"Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications" by Scott V Joy

Selected Works of Jason Goebel, MD

Follow Contact

Article

Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications

Annals of Pharmacotherapy (2005)

Scott V Joy, Duke University
Ann C Scates, Duke University
Srilaxmi Bearelly, Duke University
Moahad Dar, Duke University
Christina A Taulien, Duke University
Jason A Goebel, Duke University
Michael J Cooney, Duke University

Link

Disciplines

Pharmacology,
Endocrinology,
Medicine and Health Sciences,
Endocrinology, Diabetes, and Metabolism and
Internal Medicine

Publication Date

October 1, 2005

DOI

10.1345/APH.1E572

Citation Information

Scott V Joy, Ann C Scates, Srilaxmi Bearelly, Moahad Dar, et al.. "Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications" Annals of Pharmacotherapy Vol. 39 Iss. 10 (2005) p. 1693 - 1699
Available at: http://works.bepress.com/jason-goebel/3/